全球經皮貼片市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Transdermal Skin Patches Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: 2026年03月16日 | 出版商:

Value Market Research | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計經皮貼片市場將從 2025 年的 93 億美元成長到 2034 年的 150.2 億美元，2026 年至 2034 年的複合年成長率為 5.47%。

隨著醫療專業人員尋求便利且可控的給藥方式，全球經皮貼劑市場正穩定成長。經經皮貼片透過皮膚將藥物直接輸送到血液中，從而實現穩定的給藥效果並提高患者的遵守用藥。這些貼片廣泛用於疼痛管理、荷爾蒙療法、戒菸及其他治療。

多種因素共同推動了經皮貼片市場的擴張。慢性病盛行率的上升以及對非侵入性治療方法需求的成長，都促進了經皮給藥系統的應用。製藥公司正加大研發投入，致力於開發能提高藥物吸收率和療效的新型貼片配方。

隨著藥物傳輸技術的不斷進步，經皮貼片市場前景光明。材料和貼片設計的創新有望實現更多種類藥物的傳遞。對便捷醫療保健解決方案和個人化治療方法的日益成長的需求預計將推動該市場的持續成長。

區域分析
北美市場分析、洞察與預測
- 美國
- 加拿大
- 墨西哥
歐洲市場分析、洞察與預測
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太市場分析、洞察與預測
- 印度
- 日本
- 韓國
- 澳洲
- 東南亞
- 其他亞太國家
拉丁美洲市場分析、洞察與預測
- 巴西
- 阿根廷
- 秘魯
- 智利
- 其他拉丁美洲國家
中東和非洲市場分析、洞察與預測
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 其他中東和非洲國家

第8章競爭情勢

最新趨勢
公司分類
供應鏈和銷售管道合作夥伴（根據現有資訊）
市場佔有率和市場定位分析（基於現有資訊）
供應商情況（基於現有資訊）
策略規劃

第9章：公司簡介

主要公司的市佔率分析
公司簡介
- Teva Pharmaceutical Industries Ltd
- Novartis AG
- Teikoku Pharma USA Inc
- Viatris Inc
- Johnson & Johnson
- Luye Pharma Group
- Purdue Pharma Manufacturing LP
- Henan Lingrui Pharmaceutical Co. Ltd
- Samyang Biopharmaceuticals Corporation
- Hisamitsu Pharmaceutical Co. Inc

簡介目錄

Product Code: VMR11213473

The Transdermal Skin Patches Market size is expected to reach USD 15.02 Billion in 2034 from USD 9.30 Billion (2025) growing at a CAGR of 5.47% during 2026-2034.

The global transdermal skin patches market has grown steadily as healthcare providers seek convenient and controlled drug delivery methods. Transdermal patches deliver medication through the skin directly into the bloodstream, offering consistent dosing and improved patient compliance. These patches are widely used for pain management, hormone therapy, smoking cessation, and other medical treatments.

Several drivers are contributing to the expansion of the transdermal skin patches market. Increasing prevalence of chronic diseases and growing demand for non-invasive treatment options have encouraged the use of transdermal drug delivery systems. Pharmaceutical companies are investing in research to develop new patch formulations that improve drug absorption and therapeutic effectiveness.

Future prospects for the transdermal skin patches market appear promising as advancements in drug delivery technology continue. Innovations in materials and patch design may enable the delivery of a wider range of medications. Growing demand for convenient healthcare solutions and personalized treatment options is expected to support continued growth in this market.

MARKET SEGMENTATION

By Type

Single-Layer Drug-In-Adhesive
Multi-Layer Drug-In-Adhesive
Matrix
Other Types

By Application

Pain Relief
Smoking Reduction And Cessation Aid
Cardiovascular Disorders
Neurological Disorders
Hormonal Therapy
Other Applications

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

COMPANIES PROFILED

Teva Pharmaceutical Industries Ltd, Novartis AG, Teikoku Pharma USA Inc, Viatris Inc, Johnson Johnson, Luye Pharma Group, Purdue Pharma Manufacturing LP, Henan Lingrui Pharmaceutical Co Ltd, Samyang Biopharmaceuticals Corporation, Hisamitsu Pharmaceutical Co Inc
We can customise the report as per your requirements.

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY TYPE 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Type
4.2. Single-Layer Drug-In-Adhesive Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Multi-Layer Drug-In-Adhesive Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Matrix Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Other Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY APPLICATION 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Application
5.2. Pain Relief Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Smoking Reduction And Cessation Aid Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Hormonal Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Distribution Channel
6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY REGION 2022-2034 (USD MN)

7.1. Regional Outlook
7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Type
- 7.2.2 By Application
- 7.2.3 By Distribution Channel
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Type
- 7.3.2 By Application
- 7.3.3 By Distribution Channel
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Type
- 7.4.2 By Application
- 7.4.3 By Distribution Channel
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Type
- 7.5.2 By Application
- 7.5.3 By Distribution Channel
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 Rest of Latin America
7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Type
- 7.6.2 By Application
- 7.6.3 By Distribution Channel
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

8.1. Recent Developments
8.2. Company Categorization
8.3. Supply Chain & Channel Partners (based on availability)
8.4. Market Share & Positioning Analysis (based on availability)
8.5. Vendor Landscape (based on availability)
8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL TRANSDERMAL SKIN PATCHES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Company Profiles
- 9.2.1 Teva Pharmaceutical Industries Ltd
- 9.2.2 Novartis AG
- 9.2.3 Teikoku Pharma USA Inc
- 9.2.4 Viatris Inc
- 9.2.5 Johnson & Johnson
- 9.2.6 Luye Pharma Group
- 9.2.7 Purdue Pharma Manufacturing LP
- 9.2.8 Henan Lingrui Pharmaceutical Co. Ltd
- 9.2.9 Samyang Biopharmaceuticals Corporation
- 9.2.10 Hisamitsu Pharmaceutical Co. Inc